377 related articles for article (PubMed ID: 24925222)
1. GNAS is frequently mutated in both low-grade and high-grade disseminated appendiceal mucinous neoplasms but does not affect survival.
Singhi AD; Davison JM; Choudry HA; Pingpank JF; Ahrendt SA; Holtzman MP; Zureikat AH; Zeh HJ; Ramalingam L; Mantha G; Nikiforova M; Bartlett DL; Pai RK
Hum Pathol; 2014 Aug; 45(8):1737-43. PubMed ID: 24925222
[TBL] [Abstract][Full Text] [Related]
2. Molecular and clinicopathological features of appendiceal mucinous neoplasms.
Yanai Y; Saito T; Hayashi T; Akazawa Y; Yatagai N; Tsuyama S; Tomita S; Hirai S; Ogura K; Matsumoto T; Wada R; Yao T
Virchows Arch; 2021 Mar; 478(3):413-426. PubMed ID: 32821969
[TBL] [Abstract][Full Text] [Related]
3. A mutation spectrum that includes GNAS, KRAS and TP53 may be shared by mucinous neoplasms of the appendix.
Hara K; Saito T; Hayashi T; Yimit A; Takahashi M; Mitani K; Takahashi M; Yao T
Pathol Res Pract; 2015 Sep; 211(9):657-64. PubMed ID: 26160192
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneous mutational profile and prognosis conferred by TP53 mutations in appendiceal mucinous neoplasms.
Zhu X; Salhab M; Tomaszewicz K; Meng X; Mathew C; Bathini V; Switzer B; Walter O; Cosar EF; Wang X; Lambert LA; Hutchinson LM
Hum Pathol; 2019 Mar; 85():260-269. PubMed ID: 30458197
[TBL] [Abstract][Full Text] [Related]
5. Mutation profile of high-grade appendiceal mucinous neoplasm.
Liao X; Vavinskaya V; Sun K; Hao Y; Li X; Valasek M; Xu R; Polydorides AD; Houldsworth J; Harpaz N
Histopathology; 2020 Feb; 76(3):461-469. PubMed ID: 31491041
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic and molecular analysis of disseminated appendiceal mucinous neoplasms: identification of factors predicting survival and proposed criteria for a three-tiered assessment of tumor grade.
Davison JM; Choudry HA; Pingpank JF; Ahrendt SA; Holtzman MP; Zureikat AH; Zeh HJ; Ramalingam L; Zhu B; Nikiforova M; Bartlett DL; Pai RK
Mod Pathol; 2014 Nov; 27(11):1521-39. PubMed ID: 24633196
[TBL] [Abstract][Full Text] [Related]
7. KRAS and GNAS Co-Mutation in Metastatic Low-Grade Appendiceal Mucinous Neoplasm (LAMN) to the Ovaries: A Practical Role for Next-Generation Sequencing.
Matson DR; Xu J; Huffman L; Barroilhet L; Accola M; Rehrauer WM; Weisman P
Am J Case Rep; 2017 May; 18():558-562. PubMed ID: 28526814
[TBL] [Abstract][Full Text] [Related]
8. Frequent GNAS mutations in low-grade appendiceal mucinous neoplasms.
Nishikawa G; Sekine S; Ogawa R; Matsubara A; Mori T; Taniguchi H; Kushima R; Hiraoka N; Tsuta K; Tsuda H; Kanai Y
Br J Cancer; 2013 Mar; 108(4):951-8. PubMed ID: 23403822
[TBL] [Abstract][Full Text] [Related]
9. Loss of SMAD4 protein expression is associated with high tumor grade and poor prognosis in disseminated appendiceal mucinous neoplasms.
Davison JM; Hartman DA; Singhi AD; Choudry HA; Ahrendt SA; Zureikat AH; Ramalingam L; Nikiforova M; Pai RK
Am J Surg Pathol; 2014 May; 38(5):583-92. PubMed ID: 24618609
[TBL] [Abstract][Full Text] [Related]
10. GNAS mutation is a frequent event in pancreatic intraductal papillary mucinous neoplasms and associated adenocarcinomas.
Hosoda W; Sasaki E; Murakami Y; Yamao K; Shimizu Y; Yatabe Y
Virchows Arch; 2015 Jun; 466(6):665-74. PubMed ID: 25796395
[TBL] [Abstract][Full Text] [Related]
11. GNAS mutations in primary mucinous and non-mucinous lung adenocarcinomas.
Ritterhouse LL; Vivero M; Mino-Kenudson M; Sholl LM; Iafrate AJ; Nardi V; Dong F
Mod Pathol; 2017 Dec; 30(12):1720-1727. PubMed ID: 28776576
[TBL] [Abstract][Full Text] [Related]
12. Molecular Profiling of Appendiceal Adenocarcinoma and Comparison with Right-sided and Left-sided Colorectal Cancer.
Tokunaga R; Xiu J; Johnston C; Goldberg RM; Philip PA; Seeber A; Naseem M; Lo JH; Arai H; Battaglin F; Puccini A; Berger MD; Soni S; Zhang W; Hwang JJ; Shields AF; Marshall JL; Baba H; Korn WM; Lenz HJ
Clin Cancer Res; 2019 May; 25(10):3096-3103. PubMed ID: 30692096
[TBL] [Abstract][Full Text] [Related]
13. Molecular profiling of appendiceal epithelial tumors using massively parallel sequencing to identify somatic mutations.
Liu X; Mody K; de Abreu FB; Pipas JM; Peterson JD; Gallagher TL; Suriawinata AA; Ripple GH; Hourdequin KC; Smith KD; Barth RJ; Colacchio TA; Tsapakos MJ; Zaki BI; Gardner TB; Gordon SR; Amos CI; Wells WA; Tsongalis GJ
Clin Chem; 2014 Jul; 60(7):1004-11. PubMed ID: 24821835
[TBL] [Abstract][Full Text] [Related]
14. GNAS mutations are associated with mucin production in low-grade appendiceal mucinous neoplasms, villous adenomas, and carcinomas.
Zauber P; Marotta S; Sabbath-Solitare M
Hum Pathol; 2015 Feb; 46(2):339. PubMed ID: 25466964
[No Abstract] [Full Text] [Related]
15. Intraductal papillary mucinous neoplasms of the pancreas with distinct pancreatic ductal adenocarcinomas are frequently of gastric subtype.
Ideno N; Ohtsuka T; Kono H; Fujiwara K; Oda Y; Aishima S; Ito T; Ishigami K; Tokunaga S; Ohuchida K; Takahata S; Nakamura M; Mizumoto K; Tanaka M
Ann Surg; 2013 Jul; 258(1):141-51. PubMed ID: 23532108
[TBL] [Abstract][Full Text] [Related]
16. Appendiceal mucinous neoplasms: a clinicopathologic analysis of 107 cases.
Misdraji J; Yantiss RK; Graeme-Cook FM; Balis UJ; Young RH
Am J Surg Pathol; 2003 Aug; 27(8):1089-103. PubMed ID: 12883241
[TBL] [Abstract][Full Text] [Related]
17. Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei".
Ronnett BM; Zahn CM; Kurman RJ; Kass ME; Sugarbaker PH; Shmookler BM
Am J Surg Pathol; 1995 Dec; 19(12):1390-408. PubMed ID: 7503361
[TBL] [Abstract][Full Text] [Related]
18. Molecular and Genetic Markers in Appendiceal Mucinous Tumors: A Systematic Review.
Stein A; Strong E; Clark Gamblin T; Clarke C; Tsai S; Thomas J; George B; Mogal H
Ann Surg Oncol; 2020 Jan; 27(1):85-97. PubMed ID: 31583543
[TBL] [Abstract][Full Text] [Related]
19. GNAS but Not Extended RAS Mutations Spectrum are Associated with a Better Prognosis in Intraductal Pancreatic Mucinous Neoplasms.
Gaujoux S; Parvanescu A; Cesaretti M; Silve C; Bieche I; Rebours V; Lévy P; Sauvanet A; Cros J
Ann Surg Oncol; 2019 Aug; 26(8):2640-2650. PubMed ID: 31025231
[TBL] [Abstract][Full Text] [Related]
20. Histological Subtype Remains a Significant Prognostic Factor for Survival Outcomes in Patients With Appendiceal Mucinous Neoplasm With Peritoneal Dissemination.
Huang Y; Alzahrani NA; Chua TC; Morris DL
Dis Colon Rectum; 2017 Apr; 60(4):360-367. PubMed ID: 28267002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
